GEODE CAPITAL MANAGEMENT, LLC - OCUPHIRE PHARMA INC ownership

OCUPHIRE PHARMA INC's ticker is OCUP and the CUSIP is 67577R102. A total of 50 filers reported holding OCUPHIRE PHARMA INC in Q3 2023. The put-call ratio across all filers is 0.24 and the average weighting 0.1%.

Quarter-by-quarter ownership
GEODE CAPITAL MANAGEMENT, LLC ownership history of OCUPHIRE PHARMA INC
ValueSharesWeighting
Q3 2023$734,212
-12.8%
219,113
+12.9%
0.00%
Q2 2023$842,172
+23.8%
194,049
+7.0%
0.00%
Q1 2023$680,137
+111397.9%
181,370
+4.8%
0.00%
Q4 2022$610
-99.8%
173,067
+14.2%
0.00%
Q3 2022$304,000
+7.4%
151,569
+2.8%
0.00%
Q2 2022$283,000
-32.6%
147,459
+13.5%
0.00%
Q1 2022$420,000
+23.9%
129,924
+42.7%
0.00%
Q4 2021$339,000
-16.5%
91,068
+15.4%
0.00%
Q3 2021$406,000
+200.7%
78,923
+208.4%
0.00%
Q2 2021$135,000
+107.7%
25,594
+126.5%
0.00%
Q1 2021$65,00011,3000.00%
Other shareholders
OCUPHIRE PHARMA INC shareholders Q3 2023
NameSharesValueWeighting ↓
Richmond Brothers, Inc. 340,526$1,276,9762.16%
Knoll Capital Management, LLC 100,000$375,0000.58%
RICE HALL JAMES & ASSOCIATES, LLC 809,117$3,034,1890.17%
Diametric Capital, LP 55,648$208,6800.10%
MAI Capital Management 494,690$1,855,0880.03%
TRUST CO OF TOLEDO NA /OH/ 26,000$97,5000.02%
Bedel Financial Consulting, Inc. 15,000$56,2500.01%
Legato Capital Management LLC 16,456$61,7100.01%
OCCUDO QUANTITATIVE STRATEGIES LP 19,623$73,5860.01%
Cornerstone Capital, Inc. 16,357$61,3390.01%
View complete list of OCUPHIRE PHARMA INC shareholders